Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Brok IC"'
Autor:
van den Bijgaart RJE; Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Kroesen M; Holland Proton Therapy Center, Delft, The Netherlands., Brok IC; Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Reijnen D; Central Animal Laboratory, Radboud University Medical Center, Nijmegen, The Netherlands., Wassink M; Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Boon L; Bioceros, Utrecht, The Netherlands., Hoogerbrugge PM; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Adema GJ; Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2020 Sep 20; Vol. 9 (1), pp. 1817653. Date of Electronic Publication: 2020 Sep 20.
Autor:
van den Bijgaart RJE; From the Radiotherapy and OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Kroesen M; the Department of Radiotherapy, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands., Wassink M; From the Radiotherapy and OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Brok IC; From the Radiotherapy and OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Kers-Rebel ED; From the Radiotherapy and OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Boon L; Bioceros, 3584 CM Utrecht, The Netherlands., Heise T; the Cluster for Molecular Chemistry, Institute for Molecules and Materials, Radboud University, 6525 AJ Nijmegen, The Netherlands., van Scherpenzeel M; the Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, 6525 DA Nijmegen, the Netherlands, and., Lefeber DJ; the Translational Metabolic Laboratory, Department of Laboratory Medicine, Radboud University Medical Center, 6525 DA Nijmegen, the Netherlands, and., Boltje TJ; the Cluster for Molecular Chemistry, Institute for Molecules and Materials, Radboud University, 6525 AJ Nijmegen, The Netherlands., den Brok MH; From the Radiotherapy and OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Hoogerbrugge PM; the Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Büll C; From the Radiotherapy and OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., Adema GJ; From the Radiotherapy and OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands, gosse.adema@radboudumc.nl.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2019 Mar 22; Vol. 294 (12), pp. 4437-4449. Date of Electronic Publication: 2019 Jan 22.
Autor:
Kroesen M; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Pediatric Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Büll C; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, The Netherlands., Gielen PR; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, The Netherlands., Brok IC; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, The Netherlands., Armandari I; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, The Netherlands., Wassink M; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, The Netherlands., Looman MW; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, The Netherlands., Boon L; EPIRUS Biopharmaceuticals Netherlands B.V. , Utrecht, The Netherlands., den Brok MH; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, The Netherlands., Hoogerbrugge PM; Department of Pediatric Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; Princes Máxima Center for Pediatric Oncology, De Bilt, The Netherlands., Adema GJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center , Nijmegen, The Netherlands.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2016 Mar 28; Vol. 5 (6), pp. e1164919. Date of Electronic Publication: 2016 Mar 28 (Print Publication: 2016).
Autor:
Kroesen M; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences/278 TIL, Radboud University Medical Center, Post Box 9101, 6500 HB, Nijmegen, The Netherlands., Brok IC, Reijnen D, van Hout-Kuijer MA, Zeelenberg IS, Den Brok MH, Hoogerbrugge PM, Adema GJ
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2015 May; Vol. 64 (5), pp. 563-72. Date of Electronic Publication: 2015 Feb 17.
Autor:
Kroesen M; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Pediatric Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Gielen P; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands; These authors contributed equally to this work., Brok IC; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands; These authors contributed equally to this work., Armandari I; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands., Hoogerbrugge PM; Department of Pediatric Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands; Princes Máxima Center for Pediatric Oncology, The Bilt, The Netherlands., Adema GJ; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.
Publikováno v:
Oncotarget [Oncotarget] 2014 Aug 30; Vol. 5 (16), pp. 6558-72.